This was also demonstrated within our triple negative breast cancer cell lines, where FAK inhibition reduced self-renewal in the SUM159 cell line, which is established from a breast tumour primary but not in the MDA-MB-231 cell line which is established from a metastatic pleural aspirate. The gene discussed is PTK2; the disease is triple-negative breast carcinoma.